Page 131 - CIBERER-2015-eng

Most relevant scientific articles
Research Groups
santos a, resmini e, gómeZ-ansón B, cresPo i, granell e, Valassi e, Pires P, ViVes-gilaBert Y, martíneZ-momBlán ma, de Juan m, mataró m, WeBB sm. Cardiovascular risk and white matter lesions after endocrine control of Cush- ing’s syndrome. Eur J Endocrinol. 2015 Dec;173(6):765- 75. doi: 10.1530/EJE-15-0600. PMID: 26497546
cresPo i, santos a, Valassi e, Pires P, WeBB sm, resmini e. Impaired decision making and delayed memory are related with anxiety and depressive symptoms in acro-
10.1371/journal.pone.0120185. eCollection 2015. PMID: 25799396
andela cd, Van haalen Fm, ragnarsson o, PaPaKoK- Kinou e, Johannsson g, santos a, WeBB sm, BiermasZ nr, Van der Wee nJ, Pereira am. MECHANISMS IN EN- DOCRINOLOGY: Cushing’s syndrome causes irreversible effects on the human brain: a systematic review of struc- tural and functional magnetic resonance imaging studies. Eur J Endocrinol. 2015 Jul;173(1):R1-14. doi: 10.1530/
megaly. Endocrine. 2015 Dec;50(3):756-63. doi: 10.1007/ s12020-015-0634-6. PMID: 26018738
aulinas a, ramíreZ mJ, Barahona mJ, Valassi e, resmini e, mato e, santos a, cresPo i, Bell o, surrallés J, WeBB sm. Dyslipidemia and chronic inflammation markers are correlated with telomere length shortening in Cushing’s syndrome. PLoS One. 2015 Mar 23;10(3):e0120185. doi:
Highlights
The U747 performs clinical research oriented to Rare Pituitary Diseases, with translation to the NHS, registries and collaborations with patient associ- ations. In translation we have continued to collab- orate with EPIRARE, Orphanet-Spain and the PI is the coordinator of the CIBERER program “Endocrine Medicine”; in 2015 with the 5 linked clinical groups, a translational research project has been funded by CIBERER as well as a Personalized Medicine ISCI- II project. Since 1982, the PI is responsible of spe- cialized clinics for Rare Pituitary Diseases, and is a recognized reference centre due to its professional excellence. We have obtained a new publically fund- ed research project PI 14/000194, ISCIII: “Study of bone microarchitecture and resistance and their de- termining factors in Cushing syndrome or acromeg- aly in remission. Model to investigate the interaction bone- body fat”.
We have continued to collaborate in patients meet- ings collaborating with the associations of acro- megaly and Addison’s disease patients.
EJE-14-1101. PMID: 25650405
dénes J, sWords F, rattenBerrY e, stals K, oWens m, cranston t, et al. Heterogeneous genetic background of the association of pheochromocytoma/ paraganglioma and pituitary adenoma: results from a large patient co- hort. J Clin Endocrinol Metab. 2015 Mar;100(3):E531-41. doi: 10.1210/jc.2014-3399. PMID: 25494863
In transference to the productive market, we have been involved in clinical trials (in phase 2, 3 and 4), epidemiological Studies, R&D&I and several adviso- ry boards on Rare Pituitary Diseases, and have thus funded the salary of a research nurse.
The copyright fees of the PI and the ascribed re- searcher X Badia of the specific quality of life ques- tionnaires for acromegaly, Cushing’s sd (and re- cently also for primary hyperparathyroidism), are also fed back into the Group to hire a predoctoral research fellow.
The Agencia de Gestió d’Ajuts Universitaris i de Re- cerca (AGAUR) has recognized the Group (355) in the call for Support for Research Groups, and clas- sified it as the 4th (the first clinical group) of the 60 groups of the IIB-S Pau, demonstrating its internal and external value.
Institution: Inst. de Investigación Hospital de la Santa Creu i Sant Pau · Contact: S. Antoni Ma Claret, 167 08025 Barcelona · Tels: 93 553 79 17 o 93 556 56 61 · E.mail: [email protected]
CIBERER I Annual report 2015 I 131